Siponimod
Siponimod
Siponimod (pronounced sih-POH-nih-mod) is a medication used in the treatment of multiple sclerosis, a chronic disease that affects the central nervous system. It is a type of immunomodulator, which means it works by modifying the body's immune response.
Etymology
The name "Siponimod" is derived from the chemical structure of the drug. It is a synthetic compound, and its name is an abbreviation of its chemical name, which is 2-amino-2-[2-(4-octylphenyl)ethyl]propane-1,3-diol.
Usage
Siponimod is used to treat relapsing forms of multiple sclerosis, including clinically isolated syndrome, relapsing-remitting disease, and active secondary progressive disease. It is not a cure for multiple sclerosis, but it can help to slow the progression of disability and reduce the frequency of relapse symptoms.
Mechanism of Action
Siponimod works by binding to the sphingosine-1-phosphate receptor, which is found on the surface of certain types of white blood cells. This binding action prevents these cells from leaving the lymph nodes and entering the central nervous system, where they can cause inflammation and damage to nerve cells.
Side Effects
Common side effects of Siponimod include headache, high blood pressure, and liver function abnormalities. Serious side effects can include a slow heart rate, infections, and vision problems.
Related Terms
External links
- Medical encyclopedia article on Siponimod
- Wikipedia's article - Siponimod
This WikiMD article is a stub. You can help make it a full article.
Languages: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
Urdu,
বাংলা,
తెలుగు,
தமிழ்,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
European
español,
Deutsch,
français,
русский,
português do Brasil,
Italian,
polski